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a  b  s  t  r  a  c  t
Furin  is  a  proprotein  convertase  enzyme.  In  the  liver,  it  cleaves  prohepcidin  to  form  active
hepcidin-25,  which  regulates  systemic  iron  homeostasis.  Hepcidin  deﬁciency  is a  com-
ponent  of  several  iron  overload  disorders,  including  -thalassemia.  Several  studies  have
identiﬁed  factors  that  repress  hepcidin  gene  transcription  in  iron  overload.  However,  the
effect  of  iron  overload  on furin,  a post-translational  regulator  of  hepcidin,  has  never been
evaluated.  The  present  study  aimed  to  investigate  the  changes  in furin  and  related  factors
in parenteral  iron-overloaded  mice,  including  those  with  -thalassemia.  Wild-type  (WT)
and  -thalassemia  intermedia  (th3/+)  C57BL/6  mice  were  intraperitoneally  injected  with  9
doses  of  iron  dextran  (1 g iron/kg  body  weight)  over  2 weeks.  In the  iron  overload  condition,
our  data  demonstrated  a signiﬁcant  Furin  mRNA  reduction  in  WT  and  th3/+  mice.  In addi-
tion,  the  liver  furin  protein  level  in  iron-overloaded  WT  mice  was  signiﬁcantly  reduced  by
70% compared  to  control  WT  mice.  However,  the  liver  furin  protein  in iron-overloaded  th3/+
mice did not  show  a signiﬁcant  reduction  compared  to control  th3/+  mice.  The  hepcidin  gene
(hepcidin antimicrobial  peptide  gene,  Hamp1)  expression  was  increased  in  iron-overloaded
WT  and  th3/+  mice.  Surprisingly,  the  liver  hepcidin  protein  level  and  total serum  hepcidin
were  not  increased  in both  WT  and  th3/+  mice  with  iron  overload,  regardless  of  the  increase
in Hamp1  mRNA.  In  conclusion,  we  demonstrate  furin  downregulation  in conjunction  with
Hamp1  mRNA-unrelated  pattern  of  hepcidin  protein  expression  in  iron-overloaded  mice,
particularly  the  WT  mice,  suggesting  that,  not  only  the  amount  of  hepcidin  but also  the
furin-mediated  physiological  activity  may  be  decreased  in  severe  iron  overload  condition.
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1. Introduction
Furin belongs to the family of enzymes called “pro-
protein convertases” which localize as transmembrane
proteins in the trans-Golgi network, endosomes, and at
the cell surface along the protein-sorting pathway. Furin
converts various proproteins to mature proteins [1,2]. It
plays a role in post-translational modiﬁcation of hep-
cidin, a liver peptide hormone that regulates systemic iron
homeostasis. Increased hepcidin synthesis limits intesti-
nal iron absorption, whereas hepcidin deﬁciency promotes
iron absorption. Hepcidin is initially synthesized as a pro-
hormone. Therefore, it must undergo a maturation process
via furin cleavage to become an active hormone containing
25 amino acids [3–5].
Iron overload is an important clinical manifestation
in -thalassemia that is caused by blood transfusion
and increased iron absorption secondary to ineffective
erythropoiesis. The liver iron content (LIC) greater than
7.0–15.0 mg/g liver dry weight is considered to represent
an increased risk of fatal complications in -thalassemia
patients [6,7]. Despite iron overload, the levels of serum
and urine hepcidin are extremely low, which contribute to
the progressive iron absorption in these patients [8,9].
Whereas most studies of iron overload focused on
the changes in transcriptional regulation of hepcidin, the
changes in factors inﬂuencing post-translation processes,
especially furin, are still unknown. In the liver, furin is
regulated by transferrin receptor 2 (TfR2), an iron-sensing
molecule located on the hepatocyte cell surface. TfR2
(with HFE) activates furin expression through mitogen-
activated protein kinase/extracellular signal-regulated
kinase (MAPK/Erk) signaling [10]. Moreover, a previous
study has shown a signiﬁcant decrease in TfR2 in parenteral
iron-loaded C57BL/6 mice [11], which led us to ask whether
this iron overload could also affect furin expression.
Several mouse models have been established to study
the pathophysiology and to identify novel therapeutics in
-thalassemia [12]. Furthermore, some mouse models of
iron overload (both -thalassemia and others) mimic  the
iron burden patients after administration of exogenous iron
to the mice [13,14]. For example, iron dextran was  injected
in th1/th1 mouse model of -thalassemia intermedia to
generate a severe form of iron overload, and changes of
various parameters including iron accumulation in target
organs (i.e. serum, bone marrow, liver, spleen, and heart),
red blood cell production in medullary site (bone marrow)
and extramedullary sites (liver and spleen), and liver hep-
cidin gene expression were subsequently examined [15].
We  investigated the effect of parenteral iron overload
on the changes in furin and related parameters in both
WT and th3/+ mice in a C57BL/6 background. Our model
represents severe iron-overloaded condition without (WT)
and with (th3/+) the underlying ineffective erythropoiesis
[16]. We  hypothesized that iron overload may  affect liver
Fig. 1. Schedule of animports 2 (2015) 415–422
furin expression, and subsequently disrupt the production
of physiologically active hepcidin.
2. Materials and methods
2.1. Animals
Seven week old WT and th3/+ mice (both male and
female) on a C57BL/6 background were obtained from the
Thalassemia Research Center, Institute of Molecular Bio-
sciences, Mahidol University, Thailand. The phenotype of
th3/+ mice is comparable to -thalassemia intermedia in
humans, including mild anemia (hemoglobin level ∼8 g/dl),
low red blood cell counts with the increase in reticulocytes,
and enlarged spleen size [17]. The mice were acclimatized
under conventional sterile conditions at 20 ± 2 ◦C with reg-
ular chow and water in a 12 h light/dark cycle and 60 ± 10%
humidity for 1 week prior to the experiments. All exper-
imental protocols were approved by the Animal Ethics
Committee of the Faculty of Science, Mahidol University
(Protocol No. 29 and MUSC56-004-266).
2.2. Experimental design
WT  and th3/+ mice were divided into 2 groups (5
mice each, containing both male and female): one con-
trol (0.9% NaCl treatment) and one iron overload group.
To induce iron overload, the mice were intraperitoneally
(i.p.) injected with iron dextran (Sigma, St. Louis, MO)  at
a dose of 1 g iron/kg body weight for a total of 9 doses
over 15 days as shown in Fig. 1. Ten days after the com-
pletion of the animal treatments, the mice were weighed
and sacriﬁced. Blood samples were collected via cardiac
puncture, and the sera were separated. Livers and spleens
were subsequently harvested and weighed. Each liver sam-
ple was  dissected into 3 parts: (1) stored at −80 ◦C for the
measurement of iron content and western blot analysis,
(2) immersed in RNAlater® (Sigma) and stored at −20 ◦C
for real-time RT-PCR, and (3) ﬁxed in 10% neutral buffered
formalin for immunoﬂuorescence.
2.3. Determination of liver iron content
The non-heme iron content was analyzed by the fer-
rozine method [18,19]. In brief, the liver sample was
weighed and homogenized in 1 ml  of 0.1 M PBS buffer,
pH 7.4. Iron was extracted by adding an equal volume of
liver tissue homogenate (250 l) and protein precipitants
(125 l of 1 N HCl and 125 l of 10% trichloroacetic acid,
Sigma). After mixing, the solution was incubated in a water
bath at 95 ◦C for 45 min. Next, the solution was cooled at
room temperature for 5 min, followed by centrifugation at
3500 rpm for 15 min. The supernatant was  collected, and
the precipitate was resuspended with protein precipitants
to extract the remaining iron. An additional supernatant
al treatment.
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as then collected. To analyze the iron content, the super-
atant was diluted with 1 N HCl to a total volume of
00 l and further mixed with 1 ml  of chromogen solution
0.5 mM ferrozine, 50 mM sodium ascorbate, and 1.05 M
odium acetate, Sigma). After 20 min  incubation at room
emperature, the absorbance was measured at 562 nm
sing the Cintra 10e UV visible spectrophotometer (GBC;
elbourne, VIC, Australia).
.4. Measurements of serum erythropoietin and hepcidin
Serum erythropoietin (sEPO) and hepcidin were mea-
ured using the EPO Mouse ELISA kit (ab119593, Abcam,
ambridge, MA)  and Mouse Hepcidin Antimicrobial Pep-
ide (HAMP) ELISA kit (E03H0051, Blue Gene, Shanghai,
hina), respectively, according to the manufacturer’s
nstructions.
.5. Quantiﬁcation of Hamp1, Tfr2, and Furin mRNA
xpression
Total liver RNA was isolated using the UltracleanTM
issue & Cells RNA isolation kit (MO  BIO Laboratories,
arlsbad, CA) according to the manufacturer’s instruc-
ions. The mRNA expression of Hamp1, Tfr2, and Furin
as examined by real-time RT-PCR using the SYBR®
reen One-Step qRT-PCR kit (11736-051, Invitrogen,
arlsbad, CA). The oligonucleotide primers (Invitrogen)
sed were 5′-AGAGCTGCAGCCTTTGCAC-3′ (forward) and
′-ACACTGGGAATTGTTACAGCATT-3′ (reverse) for Hamp1
20]; 5′-CAGCCTCGGTACACACAGAT-3′ (forward) and 5′-
GCTACACCTACGCCACAGA-3′ (reverse) for Furin [21];
′-CCTCTATGAACAAGTGGCACTCA-3′ (forward) and 5′-
CCGATCATCCTCCATGAAG-3′ (reverse) for Tfr2; 5′-TCC-
GGCCTCACTGTCCAC-3′ (forward) and 5′-GTCCGCCTA-
AAGCACTTGC-3′(reverse) for ˇ-actin [22]. In a single 25 l
CR reaction, 1 l of total RNA was added. The target
equences were ampliﬁed in duplicate by an ABI PRISM
500 thermal cycler (Applied Biosystems; Foster City, CA)
sing the following program: 50 ◦C for 3 min; 95 ◦C for
 min; 40 cycles of 95 ◦C for 15 s, 60 ◦C for 30 s, and 40 ◦C
or 1 min; and a ﬁnal melting curve analysis. Relative quan-
iﬁcation was performed using the Pfafﬂ method [23], and
-actin was chosen as the normalizer.
.6. Liver furin protein detection and quantiﬁcation
Liver tissue samples were homogenized in RIPA buffer
with protease inhibitors) and centrifuged for 20 min  at
0,000 × g at 4 ◦C. The supernatant was then collected.
ext, the concentration of protein was measured by Lowry
ethod [24]. Western blot analyses were performed as
reviously described [25]. Brieﬂy, proteins (20 g/lane)
ere loaded into 10% SDS-polyacrylamide gel. After elec-
rophoresis and electrotransfer, the blots were blocked
y 5% skim milk in phosphate-buffered saline (PBS) pH
.4 with 0.1% (v/v) Tween 20 (PBST) for 1 h and washed times with PBST. Membranes were then incubated at
◦C overnight with rabbit anti-furin polyclonal antibody
1:200) (sc-20801, Santa Cruz Biotechnology, Santa Cruz,
A) or rabbit anti--actin polyclonal antibody (1:3000)ports 2 (2015) 415–422 417
(4967S, Cell Signaling Technology). Membranes were
washed 3 times with PBST followed by a 1 h incubation
at room temperature with enhanced chemiluminescence
(ECL), donkey anti-rabbit IgG, HRP-linked secondary anti-
body (dilution 1:10,000) (NA934, GE Healthcare). After
washing 3 times with PBST, the protein bands were visu-
alized using ClarityTM western ECL substrate (170-5060,
Bio-Rad, Hercules, CA) according to the protocol. -actin
was used as a loading control.
2.7. Liver hepcidin protein detection and quantiﬁcation
Hepcidin protein in liver tissue was detected by
immunoﬂuorescence. The slides of formalin-ﬁxed,
parafﬁn-embedded liver tissue sections (5 m thick) were
heated at 80 ◦C for 30 min  and deparafﬁnized by a 3-step
immersion into Unyhol Plus® solution (Bio-Optica, Milano,
Italy) (once for 10 min  and twice for 5 min). Next, the
tissues were rehydrated in a graded ethanol series (15 min
in 100%, 15 min  in 95%, and 5 min  in 80%), followed by
immersion in 0.25% NH3 in 70% ethanol for 1 h and 50%
ethanol for 10 min  [26]. Then, the slides were rinsed with
distilled water and washed twice with 1× PBS (5 min
each). For antigen retrieval, the slides were immersed
in Tris–EDTA buffer (10 mM Tris base, 1 mM EDTA, and
0.05% Tween 20, pH 9.0), preheated in a water bath at
95 ◦C, and incubated for 40 min. After cooling at room
temperature for 20 min, the tissue slides were treated
with 0.1% Triton-X for 10 min  and washed 3 times with
1× PBS (5 min  each). The tissue sections were blocked
with 5% normal goat serum in 3% BSA-containing 1× PBS
for 1 h at room temperature. After removing the blocking
agent, the samples were incubated with 20 g/ml rabbit
polyclonal anti-mouse hepcidin-25 antibody (ab81010,
Abcam) (diluted in 1× PBS containing 3% BSA) at 4 ◦C
overnight [27]. Later, the slides were washed 3 times with
1× PBS (5 min  each) before incubating the tissue sections
with ChromeoTM 488-labeled goat polyclonal anti-rabbit
IgG antibody (ab60314, Abcam) (1:1000, diluted with 2%
normal goat serum in 3% BSA-containing 1× PBS) for 1 h
at room temperature in the dark. The slides were then
washed 3 times with 1× PBS (5 min  each), immersed into
0.1% Sudan black B in 70% ethanol for 30 min, rinsed and
washed again with 1× PBS for 10 min  [26]. Finally, Prolong®
Gold antifade mounting medium (Invitrogen) was added,
and a coverslip was  placed on the slides. The ﬂuorescent
images were captured with a Fluoview FV10i-DOC laser
scanning confocal microscope (Olympus; Shinjuku, Tokyo,
Japan) with a 60 × 1.35 NA (numerical aperture) objective
lens. Fluorescence intensities were analyzed by ImageJ
Ver.1.47i software (National Institutes of Health, USA).
The summation of ﬂuorescence from 10 non-overlapping
ﬁelds was  deﬁned as the total ﬂuorescence intensity of the
sample. Using the mean total ﬂuorescence intensity in the
WT control as a calibrator, the relative quantiﬁcation was
calculated as the total ﬂuorescence intensity of the sample
divided by the ﬂuorescence intensity of the calibrator.2.8. Statistical analysis
The data are presented as the mean ± SEM. The mean
differences were compared using a Mann–Whitney U test.
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Table 1
Characteristics of the animals.
Parameter WT th3/+
Control Iron overload Control Iron overload
Body weight (g) 23.8 ± 0.9 21.6 ± 1.1 23.1 ± 0.8 21.9 ± 1.1
Liver  weight (g) 1.0 ± 0.3a 2.7 ± 0.2a 1.1 ± 0.1b 2.6 ± 0.2b
Spleen weight (mg) 73.8 ± 7.1c,d 145.3 ± 29.3c 441.8 ± 37.7d 528.5 ± 28.3
LIC  (mg/g) 0.03 ± 0.00e,f 14.5 ± 1.2f 0.21 ± 0.03e,g 14.6 ± 1.9g
Serum EPO (pg/ml) <46.9* 292.7 ± 77.9 231.0 ± 54.7 278.9 ± 48.2
1
cant diffTotal  serum hepcidin (ng/ml) 2.9 ± 1.1
The data are the mean ± SEM (n = 4–5 per group). Comparisons for signiﬁ
* Under the range of detection.
The correlation of parameters was examined by Spear-
man’s correlation analysis. A P-value <0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Characteristics of the animals
At the end of the experiment, no signiﬁcant difference
in body weight was measured among the groups of mice
(Table 1). With the same liver mass as the WT  mice, the
th3/+ mice had a markedly (approximately 6-fold) higher
spleen weight. Moreover, the th3/+ mice demonstrated sig-
niﬁcantly (approximately 7-fold) higher LICs compared to
the WT  mice.
After iron loading, the LIC signiﬁcantly increased to
15 mg/g liver wet weight in both WT  and th3/+ mice. In
addition, the liver weight increased by over 2-fold from the
baseline in both WT  and th3/+ mice. Furthermore, a similar
increase in spleen weight was observed in iron-overloaded
WT and th3/+ mice (70 and 85 mg  increase, respectively).
The baseline sEPO in WT  mice was under the range of
detection. However, a concentration of 292.7 ± 77.9 pg/ml
was detected in iron-overloaded mice (Table 1). In contrast,
the baseline sEPO level was observed at 231.0 ± 54.7 pg/ml
in th3/+ mice, and it was not changed in iron overload con-
ditions (278.9 ± 48.2 pg/ml).
3.2. Furin expression in liver
In th3/+ mice, Furin mRNA and furin protein expres-
sions were increased by 50 and 70% compared to WT
mice, respectively (Fig. 2A and 2B, respectively). Remark-
ably, Furin mRNA was signiﬁcantly decreased by 30% in
iron-overloaded WT  mice and 67% in iron-overloaded th3/+
mice. Whereas furin protein was signiﬁcantly decreased
by 70% in iron-overloaded WT  mice, it did not decrease
signiﬁcantly with iron overload in th3/+ mice (Fig. 2B).
3.3. Tfr2 mRNA expression in liver
Compared to WT mice, Tfr2 mRNA expression in th3/+
mice was not signiﬁcantly higher (P = 0.056) (Fig. 2C).
In iron-overloaded mice, Tfr2 mRNA was signiﬁcantly
decreased in both WT  and th3/+ mice (60 and 73% reduc-
tion compared to control, respectively). Furthermore, the
result of Spearman’s correlation analysis showed a strong,.1 ± 0.2 3.9 ± 0.9 1.5 ± 0.2
erences are indicated by the same letter; a, e, f, gP < 0.01, b, c, dP < 0.05.
positive correlation between Tfr2 and Furin mRNA expres-
sion (r = +0.80, P < 0.01) as shown in Fig. 2D.
3.4. Hepcidin expression
The results showed that Hamp1 mRNA (Fig. 3A), liver
hepcidin protein (Fig. 3B), and total serum hepcidin
(Table 1) in th3/+ mice did not signiﬁcantly differ from those
in WT  mice. In iron overload condition, Hamp1 mRNA was
signiﬁcantly increased by 150% in WT mice, whereas the
expression was  increased by 70% in th3/+ mice (Fig. 3A).
Surprisingly, the hepcidin protein level in both liver and
serum did not increase in iron-overloaded WT and th3/+
mice, regardless of the increased level of Hamp1 mRNA
(Fig. 3B and Table 1, respectively).
4. Discussion
According to the -globin deﬁciency in -thalassemia,
erythroid precursors undergo apoptosis. Therefore, mature
red blood cells cannot be effectively synthesized, result-
ing in a condition known as ineffective erythropoiesis (IE)
[28–30]. In th3/+ mice, we  observed the consequences of
IE, including splenomegaly, elevated sEPO, and liver iron
accumulation. The hematological parameters of this th3/+
mouse model have been described previously [17]. As in the
previous studies [17,31], our results demonstrated compa-
rable body and liver weights between the WT  and th3/+
mice.
In the presence of high sEPO and liver iron accumu-
lation, the th3/+ mice had 50% increase of Furin mRNA
expression compared to WT mice. The liver furin protein
level was also consistent with the mRNA levels (70% higher
in th3/+ mice). Serum hepcidin in normal WT mice was
2.9 ± 1.1 ng/ml, which is equivalent to the level observed
in pooled mouse sera using liquid chromatography tandem
mass spectrometry [32]. In addition, the total serum hep-
cidin and liver hepcidin protein expression in th3/+ mice
were consistent with the result of Hamp1 mRNA. With
a 7-fold increase in LIC, the level of hepcidin appeared
to be insufﬁcient in th3/+ mice [31]. Hence, it is possible
that the elevated sEPO secondary to IE may  continually
impede Hamp1 mRNA expression. Thus, the ongoing hep-
cidin insufﬁciency ultimately leads to a further increase
in intestinal iron absorption, contributing to the liver iron
accumulation in th3/+ mice [8,31].
After parenteral iron loading, the LIC was mea-
sured as ∼15 mg/g liver wet weight in both WT and
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Fig. 2. Expression of furin and related factors in the liver. The data are the mean ± SEM (n = 5 per group). (A) Relative Furin mRNA expression by real-time
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h3/+ mice. In addition, a signiﬁcant hepatosplenomegaly
as found in WT  mice and was more predominant
n th3/+ mice. Hepatosplenomegaly is a common char-
cteristic in iron-overloaded animal models and in
halassemia patients [28,30]. Although sEPO concen-
ration in WT  mice was under the range of detec-
ion of the selected technique, it was detected at
he same elevated level after iron overload in bothntitative furin protein expression. (C) Relative Tfr2 mRNA expression by
pression (all samples were included; n = 20). *P < 0.05, **P < 0.01, NS = not
WT  and th3/+ mice. In addition to our result, previ-
ous study has demonstrated the apparent increase of
both medullary and extramedullary erythropoiesis, and
reticulocyte hemoglobin content in non-anemic, iron-
overloaded C57BL/6 mice [15], which possibly supports the
notion of iron overload-mediated erythropoiesis. However,
the precise mechanism of sEPO elevation needs further
experimentation.
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 5 per gr
e staininFig. 3. Hepcidin expression in the liver. The data are the mean ± SEM (n =
ﬂuorescence images of hepcidin protein detection by immunoﬂuorescenc
**P  < 0.01, NS = not signiﬁcant.
With abundant iron loading, a signiﬁcant down-
regulation of Furin mRNA was observed in both WT  and
th3/+ mice (∼ 30 and 70% reduction, respectively). This
was conﬁrmed by the prominent reduction of furin pro-
tein in iron-overloaded WT  mice. Nonetheless, it did not
decrease signiﬁcantly in iron-overloaded th3/+ mice. We
also observed a marked Tfr2 mRNA reduction in iron-
overloaded WT  and th3/+ mice. Moreover, the strong,
positive correlation between Tfr2 and Furin mRNA expres-
sion may  support a role for TfR2 in regulating furin
expression, as previously illustrated [10]. However, the
study of changes in TfR2 protein and its signaling path-
way that regulate furin expression would further clarify
the underlying mechanism of furin down-regulation in this
iron overload condition.
In terms of hepcidin, Hamp1 mRNA was signiﬁcantly
increased in the iron overload condition. This result alsooup). (A) Relative Hamp1 mRNA expression by real-time RT-PCR. (B) Left:
g. Right: relative quantiﬁcation of hepcidin protein expression. *P < 0.05,
proves the principle that iron acts as a positive regulator of
hepcidin gene expression, which in our model overcomes
negative regulators such as elevated sEPO [33]. Neverthe-
less, the hepcidin protein levels in both the liver and serum
did not increase in iron-overloaded mice, relating to the
elevated Hamp1 mRNA expression. In addition to that aber-
rant hepcidin protein expression, the reduction of furin
may  further attenuate hepcidin function by affecting the
maturation process of hepcidin.
As shown in an in vitro study, the accumulated prohep-
cidin was  secreted from a hepatocyte cell line when furin
was  inhibited [34]. In addition, the impaired degradation
of ferroportin, a target of hepcidin, has been observed in
macrophage J774 cells after incubating with prohepcidin
plus a furin inhibitor or Furin-speciﬁc siRNA [3]. These
two  lines of evidence indicate that a substantial amount
of prohepcidin, an immature hormone, might be secreted
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n conditions of furin deﬁciency and that the prohormone
roduced is less physiologically meaningful. Therefore,
e postulate in our study that both quantity and furin-
ediated biological activity of hepcidin may  be decreased
n severe iron overload condition, including -thalassemia.
In fact, the reduction of furin may  also affect the matura-
ion process of other proteins. Insulin-like growth factor-1
IGF-1), which is mainly secreted by the liver, is a furin
ubstrate [35]. In -thalassemic patients with iron over-
oad, serum IGF-1 is signiﬁcantly lower. Lower serum
GF-1 is linked to the pathogenesis of growth failure and
steoporosis [36,37]. Our study demonstrates the possi-
le contribution of furin downregulation to the hepcidin
eﬁciency in iron overload. Potential changes in other sub-
trates, including IGF-1, could provide the basis for future
tudies related to the iron overload.
. Conclusion
We  found furin downregulation along with Hamp1
RNA-unrelated pattern of hepcidin protein expression
n iron-overloaded mice, particularly WT  mice. This result
uggests that hepcidin insufﬁciency may  involve the
ecrease in both quantity and furin-mediated biological
ctivity of hepcidin in sever iron overload condition.
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